EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal cell carcinoma with fibromyomatous stroma ( RCC FMS ) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex

Katherina Baranova iD, Jacob A Houpt iD, Deaglan Arnold, Andrew A House iD, Laura Lockau, Lindsay Ninivirta, Stephen Pautler iD, Haiying Chen, Madeleine Moussa iD, Rola Saleeb iD, Jose A Gomez, Asli Yilmaz und 6 weitere

Histopathology · 2025

DOI: 10.1111/his.15505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Katherina Baranova und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Kidney Neoplasms, Carcinoma, Renal Cell, Hemangioblastoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Sporadic renal cell carcinomas with fibromyomatous stroma (RCC FMS) with coexistent haemangioblastoma (HB)‐like morphology have been previously reported. Such morphology has not, however, been documented in patients with tuberous sclerosis complex (TSC). We evaluated clinicopathologic, immunohistochemical and molecular findings of RCC FMS with HB‐like features in three TSC patients. Methods and results All three patients were females with confirmed germline mutations in TSC1 in the absence of VHL or other alterations. One patient had bilateral nephrectomy with six separate tumours (three in each kidney), and two patients had one tumour each, resected by partial nephrectomy. Prominent fibromuscular stroma was present at the tumoral periphery and surrounding clear cell nests forming tubules and papillary formations (RCC FMS areas), admixed with solid, clear to eosinophilic and spindle cell areas (HB‐like areas). HB‐like areas were variably represented in individual tumours, but in some, HB‐like features were almost exclusive. HB‐like areas were negative for CK7 and showed inhibin‐α and S100 reactivity, in contrast to typical RCC FMS areas, which were CK7 positive, while negative for inhibin‐α and S100. GPNMB, which is consistently expressed in TSC/mTOR altered tumours, was positive in both components. On follow‐up (10 months–21 years), all patients had an indolent course.

Conclusions

HB‐like morphology found in RCC FMS in TSC patients represents part of the morphologic spectrum of RCC FMS, which is a previously underreported and underrecognized feature. RCC FMS with HB‐like areas show uniform GPNMB reactivity and are associated with TSC/MTOR alterations, but not with VHL alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous SclerosisKidney NeoplasmsCarcinoma, Renal CellHemangioblastomaHumansFemaleAdultTuberous Sclerosis Complex 1 ProteinMiddle AgedBiomarkers, Tumor

Stichwörter der Autor:innen

TSCclear cellfibromyomatous stromahaemagioblastomakidneyleiomyomatous stromarenal cell carcinoma (RCC)

Substanzen

Tuberous Sclerosis Complex 1 ProteinTSC1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada.
  • Schulich School of Medicine and Dentistry, London Health Sciences Centre, London, ON, Canada.
  • Department of Medicine, Western University and London Health Sciences Centre, London, ON, Canada.
  • Divisions of Urology and Surgical Oncology, Departments of Surgery and Oncology, Western University, London, ON, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Diagnostic and Molecular Pathology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

ORCID-Profile: Katherina Baranova, Jacob A Houpt, Andrew A House, Stephen Pautler, Madeleine Moussa, Rola Saleeb, Farshid Siadat, Kiril Trpkov

Zitieren

APA

Baranova, K., Houpt, J. A., Arnold, D., House, A. A., Lockau, L., Ninivirta, L., Pautler, S., Chen, H., Moussa, M., Saleeb, R., Gomez, J. A., Yilmaz, A., Siadat, F., Box, A., Mahoney, D. J., Zemp, F. J., Gabril, M., & Trpkov, K. (2025). Renal cell carcinoma with fibromyomatous stroma ( RCC FMS ) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex. Histopathology. https://doi.org/10.1111/his.15505

Vancouver

Baranova K, Houpt JA, Arnold D, House AA, Lockau L, Ninivirta L, et al. Renal cell carcinoma with fibromyomatous stroma ( RCC FMS ) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex. Histopathology. 2025. doi:10.1111/his.15505

BibTeX
@article{Baranova2025,
  author = {Baranova, Katherina and Houpt, Jacob A and Arnold, Deaglan and House, Andrew A and Lockau, Laura and Ninivirta, Lindsay and Pautler, Stephen and Chen, Haiying and Moussa, Madeleine and Saleeb, Rola and Gomez, Jose A and Yilmaz, Asli and Siadat, Farshid and Box, Adrian and Mahoney, Douglas J and Zemp, Franz J and Gabril, Manal and Trpkov, Kiril},
  title = {Renal cell carcinoma with fibromyomatous stroma ( RCC FMS ) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15505}
}
Kostenlos starten →